DossierENTITY

AI drug discovery

Coverage of AI drug discovery in the Nexus archive.

Earliest in view: Jun 5 · 22:35 UTCMost recent: Jun 5 · 22:35 UTC

Co-mentioned in this coverage

Recent coverage

TECHNOLOGYJun 5 · 22:35 UTCTECHCRUNCH
Reid Hoffman is leaving Microsoft’s board to go ‘founder mode’ with startup Manus
Reid Hoffman is leaving Microsoft’s board after a profitable decade to focus on his AI drug discovery startup Manus. The move shifts his attention to the startup's operations.